-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Public Health and Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience powered by Apple
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Environmental Social Governance
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions powered by Apple
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm. IQVIA and Apple are collaborating to bring this exciting future of personalized care directly to devices patients already have and use.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSBlog
Artificial Intelligence and In Vitro Diagnostics: Advancing Patient Care
Mar 11, 2019
Over the past decade, artificial intelligence (AI) has become increasingly important as a disrupter in the future of medicine. Big data and advances in technology are driving opportunities for the application of AI and machine learning (ML) in health care and clinical decision-making at an unprecedented pace.
The in vitro diagnostics (IVD) laboratory stands at the center of clinical decision-making, because of its role in data generation. A recent study on the awareness of AI in the U.S. clinical laboratory, conducted by the IQVIA™ BBC IVD Solutions team, showed that most laboratory professionals have already seen some advances driven by AI in their laboratory. As a result, they expect dramatic changes within the next two to five years in both the laboratory landscape and their routine workflow.
The IQVIA team spoke to 87 U.S. based laboratories across the core microbiology, molecular and pathology settings to understand the needs, concerns and expectations of IVD manufacturers as advances in AI and ML disrupt their current processes.
Combatting concerns and building potential
Uncertainties, including reliability, timing, patient safety and financing, remain around the feasibility of implementation and oversight of AI solutions. In the IQVIA survey, noticeable numbers of respondents were hesitant to be an early adopter of AI/ML applications focused on clinical decision. In contrast, just under 60% of participants had little to no concern pertaining to the potential implications of AI/ML. Rather, they saw AI as the next step in the evolution of laboratory technology that could reduce human error and provide objective guidance on optimal patient therapy.
On average, 87% of participants predicted that AI could have a somewhat dramatic to very dramatic impact on current diagnostic testing processes. Cost savings emerged as the most influential factor supporting the adoption of AI applications, primarily as a byproduct of reducing or replacing human labor.
Still, significant concerns exist over quality, the potential for medical errors, misdiagnosis, gaps in training of AI users, and the reliability of the AI results (e.g., “black box”). In addition, electronic medical record (EMR) and electronic health record (EHR) systems were cited as not advanced enough to deal with AI at the moment. Respondents also named upfront costs as the primary inhibitor for adoption. These included the price of the applications themselves, as well as the significant investment needed in initial training and service costs. Other important constraints included concerns surrounding FDA/regulatory approval, data security, patient safety concerns and confusion around reimbursement.
Healthcare professionals (HCPs) cannot ignore the possibilities that come with AI-based solutions. Nearly 50% of survey participants cited operational efficiency as the area of greatest immediate potential for AI applications. Within the walls of the laboratory, operational efficiency means faster turnaround time for tests, automating repetitive tasks, improving diagnostic test utilization, etc. Other major areas of potential cited included clinical decision support and standardization of care. Tool advancements in the area of reflex testing, error detection and imaging analysis were considered the most easily achievable tasks.
Implications
Nobody questions that AI will completely change and disrupt the current workflow in the laboratory, patient diagnosis and treatment, as well as the role of the key stakeholders: HCPs, laboratory staff and IVD manufacturers. The questions that remain for laboratories are:
- How do we get from A to Z without putting patients at risk?
- Who owns the data?
- How do we control the data and the output?
- How will this be regulated?
- How is it going to be paid for and reimbursed?
Laboratories have high expectations of their future relationship with IVD manufacturers and their role in bringing the implementation of AI/ML tools in the laboratory to fruition. For the IVD manufacturer this has significant implications. It will mean a completely new spectrum of responsibilities and stakeholders, and will require evolution of portfolios and services. As clinical utility needs to be demonstrated through outcomes data to drive adoption of any tool, access to real world evidence and patient data will be key moving forward.
AI also has the potential to finally address the shortage of laboratory staff/technicians that has plagued the field for years. Technology advancements have already begun to lead to the creation of new roles in data and IT (e.g., bioinformatics) for the application's upkeep and analytics. From a disease state perspective, respondents called out the opportunity to figure out more about complex conditions like cancer through clinical trial matching, and infectious disease through outbreak surveillance and prediction. By automating tasks and processing more data, AI will empower HCPs to find more meaningful solutions to both basic and complicated issues in health care.
AI tools have the potential to advance patient care, disease management, prevention and treatment, at an unprecedented level. While news outlets continue to report seemingly anecdotal breakthroughs in today's research, laboratory professionals are not wondering if, but when and how AI will play a significant role in their workflow.
To learn more about the findings of the "Artificial Intelligence Awareness and Expectations in the U.S. Laboratory" study, please contact the IQVIA team.